Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for treating nephropathy and preparation method thereof

A kidney disease and drug technology, applied in the medical field of the motherland, can solve the problems of little treatment effect and large side effects

Inactive Publication Date: 2011-04-20
丁德政
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The purpose of the present invention is to provide a medicine for treating nephropathy, so as to overcome the defects of large side effects and little therapeutic effect in existing nephropathy treatment.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine for treating nephropathy and preparation method thereof
  • Medicine for treating nephropathy and preparation method thereof
  • Medicine for treating nephropathy and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] A medicine for treating nephropathy, the mass composition of its raw material is as follows:

[0032] Astragalus 10 parts Angelica 6 parts Gastrodia 6 parts Plantago Seed 3 parts Shiitake mushroom 6 parts Cordyceps sinensis 0.5 part.

[0033] The preparation steps are as follows:

[0034] ① Pretreatment: Dry the medicinal materials, pulverize, and then pass through a 40-mesh screen, collect the powder that has passed through the screen, and place it in an extraction tank for extraction.

[0035] ②Extraction: Add distilled water 15 times the mass of medicinal materials into the extraction tank, and steam into the interlayer of the extraction tank under stirring to increase the temperature of the material to 85°C, and stir and extract for 5 hours. After the extraction is completed, centrifugal separation is performed, and the supernatant is collected and concentrated.

[0036] ③Concentration: Put the collected centrifugal supernatant in a concentrator, control the vacuum degree to...

Embodiment 2

[0042] A medicine for treating nephropathy, the mass composition of its raw material is as follows:

[0043] 35 parts of Astragalus, 10 parts of Angelica, 11 parts of Tianma, 4 parts of Plantago Seed, 10 parts of Shiitake, 2 parts of Cordyceps.

[0044] The preparation steps are as follows:

[0045] ① Pretreatment: Dry the medicinal materials, pulverize, and then pass through a 40-mesh screen, collect the powder that has passed through the screen, and place it in an extraction tank for extraction.

[0046] ②Extraction: Add distilled water 15 times the mass of medicinal materials into the extraction tank, and steam into the interlayer of the extraction tank under stirring to increase the temperature of the material to 85°C, and stir and extract for 5 hours. After the extraction is completed, centrifugal separation is performed, and the supernatant is collected and concentrated.

[0047] ③Concentration: Place the collected centrifugal supernatant in a concentrator, control the vacuum deg...

Embodiment 3

[0053] A Chinese medicine for the treatment of nephropathy, the mass composition of its raw material is as follows:

[0054] Astragalus 60 parts Angelica 15 parts Gastrodia 15 parts Plantago Seed 6 parts Shiitake mushroom 15 parts Cordyceps sinensis 3 parts.

[0055] The preparation steps are as follows:

[0056] ① Pretreatment: Dry the medicinal materials, pulverize, and then pass through a 40-mesh screen, collect the powder that has passed through the screen, and place it in an extraction tank for extraction.

[0057] ②Extraction: Add distilled water 15 times the mass of medicinal materials to the extraction tank, and steam into the interlayer of the extraction tank under stirring to raise the temperature of the material to 85°C, and then stir and extract for 5 hours. After the extraction is completed, centrifugal separation is performed, and the supernatant is collected and concentrated.

[0058] ③Concentration: Place the collected centrifugal supernatant in a concentrator, control ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of traditional Chinese medicine, in particular to a medicine for treating nephropathy and a preparation method thereof, wherein the nephropathy comprises acute and chronic nephritis, nephritic syndrome or early-stage uremia. The traditional Chinese medicine is prepared from the following pharmaceutical raw materials in parts by weight: 10-60 parts of radix astragali, 6-15 parts of angelica, 6-15 parts of rhizoma gastrodiae, 3-6 parts of plantain seed, 6-15 parts of black mushroom and 0.5-3 parts of aweto. The medicine provided by the invention decomposes immune complexes by improving the immunity and activating complements, dilates the blood vessels of the kidneys, nourishes the kidney cells, reduces the albuminuria and hematuria, promotes urination, decreases swelling, defecates, and eliminates toxicant, thereby achieving the purpose of treating both principal and secondary aspects of disease without side effects.

Description

Technical field [0001] The invention belongs to the technical field of motherland medicine, and particularly relates to a medicine for treating nephropathy and a preparation method thereof. Background technique [0002] At present, 85% of patients with nephropathy in clinical practice are caused by bacterial or viral infections and blocked immune complexes, which lead to hematuria, proteinuria, edema, hypertension and other clinical manifestations, such as nephritis and nephrotic syndrome. At present, clinical treatment of nephritis and nephrotic syndrome usually uses immunosuppressive agents to control the clinical symptoms by suppressing the immune response. However, immunosuppressants can reduce the patient’s immunity, increase the chance of infection, increase the formation of immune complexes, and make the patient’s condition repeated and aggravated. Not only can it not fundamentally solve the patient’s pain, but it will eventually develop into renal failure. [0003] Uremia ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/8988A61P13/12
Inventor 丁德政
Owner 丁德政
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com